Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRX167700 add-on to NSAIDs for knee osteoarthritis pain
2016-001443-39Phase 2Completed
- Sponsor
- Proximagen
- Start
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in knee osteoarthritis (OA) comparing PRX167700 plus stable oral NSAID with Placebo plus stable oral NSAID (2 arms). Primary endpoint: WOMAC Pain Score change from baseline to end of treatment. Started Jun 2016; status: completed.
02
Drugs
PRX167700
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on 2016-001443-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-001443-39.